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Background: KstR represses the expression of 
numerous genes responsible of the cholesterol 
catabolism in Mycobacterium. 
Results: Identification of 3-oxo-4-cholestenoic 
acid as the inducer molecule of M. smegmatis 
KstR repressor. 
Conclusion: The oxidation of the C3 and C26 of 
cholesterol is required to activate the system.  
Significance: The finding of the KstR inducer 
molecule represents new insights in developing 
new targets to fight against M. tuberculosis. 
 
Cholesterol degradation plays a prominent 
role in Mycobacterium tuberculosis infection; 
therefore, to develop new tools to combat this 
disease, we need to decipher the components 
comprising and regulating the corresponding 
pathway. A TetR-like repressor (KstR) 
regulates the upper part of this complex 
catabolic pathway, but the induction 
mechanism remains unknown. Using a 
biophysical approach we have discovered that 
the inducer molecule of KstR in M. smegmatis 
mc2155 is not cholesterol but 3-oxo-4-
cholestenoic acid, one of the first metabolic 
intermediates. Binding of this compound 
induces dramatic conformational changes in 
KstR that promote the KstR-DNA interaction 
to be released from the operator, retaining its 
dimeric state. Our findings suggest a 
regulatory model common to all cholesterol 
degrading bacteria in which the first steps of 
the pathway are critical to its mineralization, 
and explain the high redundancy of the 
enzymes involved in these initial steps. 
 
INTRODUCTION 
Mycobacterium smegmatis is a model 
organism, widely used to study the biology of 
Mycobacterium tuberculosis. Recent research 
has used this model to investigate different 
aspects of cholesterol catabolism (1-3), exploited 
as a carbon and energy source by the pathogen, 
and necessary for persistence in animal infection 
models (4). Although a compendium of 
biochemical and structural studies describe 
mycobacterial cholesterol catabolism, the 
degradation pathway and its transcriptional 
regulation are not yet fully established (5-7). The 
two first steps in cholesterol catabolism are the 
oxidation of C3 by cholesterol oxidases or 3-β-
hydroxysteroid dehydrogenase/isomerases (3-β-
HSD) (8-14) and the oxidation of C26 by P450 
cytochromes (CYP125 and CYP142) (5, 15-18), 
which are carried out sequentially and/or 
simultaneously. These biochemical reactions 
render the molecules cholest-4-en-3-ona 
(cholestenone) (after cholesterol C3 oxidation), 
3-β-hydroxy-5-cholestenoic acid (3OHChA) 
(after cholesterol C26 oxidation), and 3-oxo-4-
cholestenoic acid (3OChA) (after C3 and C26 
oxidations) (Fig. 1). Remarkably, the enzymes 
performing these biochemical reactions are 
highly redundant in M. smegmatis (11, 18, 19). 
This study aims to shed light on the 
regulation of the cholesterol degradation 
pathway in mycobacteria, which is apparently 
controlled by only two TetR-type transcriptional 
repressors: KstR and KstR2 (2, 3, 20). KstR is 
encoded by gene Rv3574 in M. tuberculosis and 
gene MSMEG_6042 in M. smegmatis, and 
controls the expression of 83 cholesterol 
catabolic genes (kstR regulon) responsible for 
activating the upper and central pathway (2, 19). 
KstR2 is encoded by gene Rv3557c in M. 
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tuberculosis and gene MSMEG_6009 in M. 
smegmatis, and controls the expression of 15 
cholesterol catabolic genes (kstR2 regulon) 
responsible for the lower pathway (3). Both 
regulators belong to the TetR family of 
transcriptional repressors, which is well 
represented and widely distributed among 
bacteria and easily recognized by their 
characteristic HTH DNA-binding motif (21). 
Several genes in the kstR regulon are essential 
for virulence, demonstrating the importance of 
cholesterol catabolism in the pathogenesis of M. 
tuberculosis (7, 22-26). KstR binds to the target 
promoters as a dimer through a conserved motif 
(TNNAACNNGTTNNA) (2, 20). Despite the 
critical role played by kstR regulon, the 
mechanisms involved in this regulation are still 
poorly understood and the inducer molecules of 
KstR are still unidentified (20). The repression 
of most described TetR-like regulators is 
released in the presence of an inducer molecule, 
causing a conformational change in the protein 
promoting gene transcription (21). Thus, KstR 
and KstR2 might be induced by cholesterol or 
cholestenone since these compounds induce the 
expression of the kstR and kstR2 regulons in vivo 
(2, 3, 19, 20). In this respect, we used EMSA 
analyses to demonstrate the ability of KstR to 
bind the MSMEG_5228 promoter region. 
However, the analyses to evaluate the KstR 
interactions with its putative inducers, i.e., 
cholesterol or cholestenone, did not render 
positive results and, therefore, we could not 
conclude that these substances directly induce 
kstR regulon (20). The crystal structure of KstR 
from M. tuberculosis has recently been revealed 
(PDB ID 3MNL), but was solved in the absence 
of inducers. 
The literature provides examples of 
regulators induced by steroids. CmeR from 
Campilobacter jejuni and BreR from Vibrio 
cholerae belong to the TetR family of regulators, 
and both repress the expression of genes that 
encode multidrug efflux system components in 
the absence of bile acids (27, 28). Researchers 
have described the crystal structure of CmeR in 
a complex with the bile acids cholate and 
taurocholate (29). Furthermore, the specific 
interaction between the negative regulator RepA 
and testosterone has been also demonstrated in 
Comamonas testosteroni (30). 
To provide further insights into the KstR-
mediated repression mechanism in mycobacteria, 
we used circular dichroism to measure the 
physical interactions of KstR with several 
intermediates of the pathway that could act as 
putative inducers. The compounds that modified 
the secondary structure of KstR were further 
tested as inducers in transcription assays in vitro. 
Our results showed that the concerted action of 
the two primary independent oxidative steps in 
cholesterol catabolism at C3 and C26 are 
necessary to produce the metabolite inducing 
kstR regulon expression.  
 
EXPERIMENTAL PROCEDURES 
 
Chemicals 
Cholesterol, cholest-4-en-3-one, 4-
androstene-3,17-dione (AD), 1,4-androstadiene-
3,17-dione (ADD), palmitic acid, palmitoyl 
alcohol, oleic acid, oleyl alcohol, 1-octanol, 
octanoic acid, decane, Tyloxapol, Tween 80, 
Triton X-100 and streptomycin sulfate were 
purchased from Sigma-Aldrich (Steinheim, 
Germany). Choles-5-ene-3β,26-diol (26-
hydroxycholesterol, 26OHCh), 3-β-hydroxy-5-
cholestenoic acid (3OHChA) and 3-oxo-4-
cholestenoic acid (3OChA) were obtained from 
Avanti Polar Lipids. 
 
Bacterial strains, plasmids, and culture 
conditions  
Bacterial strains and plasmids are listed in 
Table 1. Escherichia coli was grown in Luria-
Bertani (LB) medium (31) at 37 °C in an orbital 
shaker and, when appropriate, ampicillin (100 
µg ml-1) and kanamycin (50 µg ml-1) were added 
to the medium. M. smegmatis mc2155 was 
grown in 7H9 medium (Difco) containing 10% 
albumin-dextrose-catalase supplement (Becton 
Dickinson), 0.2% glycerol and 0.05% Tween-80 
or on 7H10 solid agar medium with the same 
supplements without Tween-80. For growth in 
glycerol, cholesterol and palmitic acid as sole 
carbon sources, 7H9 minimal medium without 
supplements was used and the carbon sources 
were added at 18, 1.8 and 3 mM, respectively. 
Stocks of 5 mM cholesterol and 8 mM palmitic 
acid were dissolved in 10% of tyloxapol with 
magnetic agitation at 80 ºC and then autoclaved. 
Gentamicin and kanamycin were used, if 
required, at a concentration of 5 µg ml-1 and 20 
µg ml-1, respectively. M. smegmatis was always 
grown at 37 ºC in an orbital shaker at 250 r.p.m. 
 
Design and cloning of the chimeric promoter 
PQ3 
The chimeric promoter PQ3 was designed 
using the sequence of the lacUV5 promoter from 
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E. coli, a mutated version of the lac promoter 
whose basal activity is dramatically less 
sensitive to intracellular levels of cyclic AMPc 
(32). The chimeric promoter PQ3 was 
synthesized by GenScript (Hong Kong) and 
contains a consensus KstR operator sequence 
(AACTGGAACGTGTTTCAGTT) (2, 20) 
overlapping the -35 and -10 boxes of the lacUV5 
promoter (Fig. 6A), according to footprinting 
assays previously described for the M. 
smegmatis P5228 native promoter (20). The six 
nucleotides located between the lacI operator 
and the Shine-Dalgarno sequence were 
substituted by the BamHI restriction site. In 
addition, two restriction sites for NdeI and SfoI 
were included four nucleotides downstream of 
the Shine-Dalgarno sequence. An EcoRI 
restriction site was also added five nucleotides 
upstream of the -35 box. The EcoRI-SfoI 
digested fragment carrying the chimeric 
promoter PQ3 was cloned into the promoter-
probe pUJ9 plasmid (Table 1). The resulting 
plasmid pUJ9PQ3 was used as a PCR template 
to amplify the synthetic promoter region using 
the primers pUJ9PQ-F and pUJ9PQ-R (Table 1) 
carrying the EcoRI and PstI restriction sites, 
respectively (indicated in bold). The PCR 
product was digested with EcoRI and PstI and 
subsequently cloned into the plasmid pJCD01, 
which contains the pUC19 polylinker flanked by 
the divergent terminators rpoCT and rrnBT1T2, 
respectively (Table 1). The resulting plasmid 
pJCDPQ3 was used as a template to amplify the 
PQ3 probe used in the electro-mobility shift 
assays (EMSA) and for the transcription assays. 
 
P5228::lacZ and PQ3::lacZ translational fusions 
construction 
To perform the in vivo experiments, plasmids 
pUJ5228 (20) and pUJ9PQ3 (Table 1) harboring 
the P5228::lacZ and PQ3::lacZ translational fusions 
respectively, were digested with NotI and ligated 
to a NotI digested plasmid pSEVA651 (33) 
(Table 1) generating plasmids pSEVAP5228 and 
pSEVAPQ3 respectively. The resulting plasmids 
were extracted from E. coli DH10B and 
electroporated into competent M. smegmatis 
∆kstR (2) cells generating the strains M. 
smegmatis mc2155 ∆kstR (pSEVAP5228) and M. 
smegmatis mc2155 ∆kstR (pSEVAPQ3), 
respectively. Then both strains were 
complemented with gene kstR. To do so, gene 
MSMEG_6042 was amplified using as a 
template the pET6042 plasmid and the 
oligonucleotides pMV6042-F and pET29bhisR 
(Table 1) carrying the PstI and SalI restriction 
sites, respectively (indicated in bold). The PCR 
product was digested with PstI and SalI and 
subsequently cloned into pMV261 (34) (Table 1). 
The resulting plasmid pMV6042 was extracted 
from E. coli DH10B and electroporated into 
competent cells of M. smegmatis ∆kstR 
(pSEVAP5228) and M. smegmatis ∆kstR 
(pSEVAPQ3) generating the strains M. 
smegmatis ∆kstR (pSEVAP5228, pMV6042) and 
M. smegmatis ∆kstR (pSEVAPQ3, pMV6042), 
respectively. As a control, the empty vector 
pMV261 was electroporated into both strains 
∆kstR (pSEVAP5228) and ∆kstR (pSEVAPQ3) 
giving rise to strains ∆ kstR (pSEVAP5228, 
pMV261) and ∆kstR (pSEVAPQ3, pMV261). 
 
KstR overexpression and purification  
The recombinant strain E. coli BL21 (DE3) 
carrying plasmid pET6042 (Table 1), 
constructed as previously described (20), was 
used to overexpress kstR. The recombinant strain 
was grown in LB containing kanamycin at 37 °C 
and 250 rpm until an A600 of 0.6. Then, 
expression of kstR was induced by adding 200 
µM isopropyl-1-thio-β-D-galactopyranoside 
(IPTG) and the strain was grown for three hours 
at 37 ºC. Cells were harvested by centrifugation 
(15 min, 5000 x g, 4 °C) and stored frozen at -20 
ºC until used. The cell pellet from 1 l culture was 
thawed on ice and resuspended in 5 ml of buffer 
A (20 mM HEPES pH 8.0 containing 0.5 M KCl) 
plus 1% Triton X-100 and disrupted by 
sonication using a Branson sonicator (four 
pulses of 1 min at 80% power, with 30 s cooling 
on ice between each). Streptomycin sulfate (2%, 
w/v) was added to the protein extract and 
vortexed until complete dissolution to facilitate 
DNA precipitation. Cell debris was removed by 
ultracentrifugation at 50,000 x g for 45 min at 
4 °C and the soluble extract was loaded onto a 
HisTrap FF crude column (GE Healthcare) 
previously equilibrated with buffer B (buffer A 
plus 5 mM of imidazol). All purification steps 
were carried out at 4 °C. The column was 
washed with 100 ml of buffer B and 100 ml of 
buffer C (buffer A containing 50 mM of 
imidazol). Protein was eluted with 50 ml of 
buffer D (buffer A containing 150 mM of 
imidazol) and the column was washed with 50 
ml of buffer A containing 500 mM of imidazol 
to ensure complete elution of the protein. The 
purity of the collected samples was analyzed by 
SDS-PAGE. The fractions containing KstR were 
concentrated to 10 mg ml-1 using AmiconUltra 
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concentrating devices (Millipore). After 
concentration, imidazole was removed by 
dialysis against 20 mM HEPES pH 8, 0.5 M KCl, 
10 mM MgCl2, 2 mM β-mercaptoethanol using a 
10,000 MVCO Slide-A-Lyzer dialysis cassette 
(Thermo) according to the manufacturer's 
specifications. The concentration of pure KstR 
was measured with a NanoPhotometer®Pearl. 
Implen, GmbH (Munich, Germany) or an 
UVmini-1240 spectrophotometer (SHIMADZU) 
by using the molar extinction coefficient at 280 
nm (18450 M-1 cm-1) calculated on the basis of 
its amino acid sequence using the ExPASy 
server (http://expasy.org/). The purified protein 
was kept at 4 °C for immediate use or at -20 °C 
with glycerol 10% for longer periods of time. 
 
Circular dichroism spectroscopy 
Circular dichroism (CD) measurements were 
carried out on taken with a JASCO J-810 
spectropolarimeter, equipped with a Peltier-type 
temperature controller and a thermostated cell 
holder, interfaced with a thermostatic bath. Far-
UV spectra were recorded in 0.1 cm path length 
quartz cells at a protein concentration of 3 µM in 
20 mM potassium phosphate buffer containing 
150 mM KCl. Five consecutive scans were 
accumulated and the average spectra stored. The 
data were corrected for the baseline contribution 
of the buffer. The observed ellipticities were 
converted into the mean residue ellipticities [θ] 
based on a mean molecular mass per residue of 
110.5 Da. Thermal denaturation was performed 
by increasing the temperature from 20 to 80° C 
at 20 °C/h, and ellipticities at 222 nm were 
measured in 0.1-cm path-length quartz cells at a 
protein concentration of 4 µM. Tm represents the 
temperature at the unfolding transition midpoint. 
The analysis of secondary structure composition 
of native proteins was performed using CDNN 
software with a reference data set of 33 proteins, 
as implemented in the program (35). 
 
Analytical ultracentrifugation  
Sedimentation velocity experiments were 
carried out using an Optima XL-I analytical 
ultracentrifuge (Beckman-Coulter) equipped 
with UV-visible absorbance optics at 20 °C in an 
AnTi50 rotor and 12-mm double sector 
centerpieces. Experiments were performed using 
1 mg ml-1 of KstR in 20 mM potassium 
phosphate buffer at pH 7.5 containing 150 mM 
KCl in the absence and in the presence of 250 
µM of palmitic acid, 3OHChA or 3OChA. The 
sedimentation coefficient distributions were 
calculated by least squares boundary modeling 
of sedimentation velocity data using the c(s) 
method, as implemented in the SEDFIT software 
(36, 37). Partial specific volume, v, for KstR 
samples without ligands was calculated at 
0.7303 mg/ml based on the amino acid sequence 
and at 0.7305 mg/ml for the KstR-250 µM 
ligands as a sum of weight fractions of ν for 
protein (0.7334) and ν for ligand (0.9880) in 
solution (38). The value of ν for the ligands 
3OHChA and 3OChA was assumed to be the 
same as cholesterol due to the high similarity of 
the molecules. 
 
Dynamic light scattering 
Dynamic light scattering experiments were 
performed with a DynaPro instrument (Protein 
Solutions Inc.). Measurements were taken at 
25°C. A solution of protein with a concentration 
of 0.25 mg ml-1 in 20 mM potassium phosphate 
buffer at pH 7.5 containing 150 mM KCl in the 
absence and in the presence of 250 µM of 
3OHChA or 3OChA was used. The software 
provided by the manufacturer was used to 
calculate the diffusion coefficient of the protein. 
 
Electro-mobility shift assays (EMSA).  
Probe 5228FP was prepared as previously 
described (20). Probe PQ3, containing the 
chimeric PQ3 promoter, was prepared in the same 
way but using pJCD01-F and pJCD01-R (Table 
1) as labeled and unlabeled oligonucleotides, 
respectively, and 10 ng of the plasmid pJCDPQ3 
as a template. Varying amounts of purified KstR 
were incubated with 0.5 nM of labeled probes in 
binding buffer (20 mM Tris-HCl at pH 8, 150 
mM KCl, 10 mM MgCl2, 10% glycerol, 2 mM 
β-mercaptoethanol, and 50 µg ml-1 BSA) in a 
final volume of 9 µl. For specific and non-
specific competition reaction mixtures, 40, 400 
or 4000-fold excess of unlabeled probe and 0.5, 
1 and 2 µg of unspecific DNA (salmon sperm) 
were added, respectively. To test the binding of 
KstR to DNA in the presence of the different 
inducers, the compounds were dissolved in 
methanol and were incubated with KstR for 10 
min at room temperature before adding the DNA 
probe. The EMSA reaction mixtures were 
incubated for 20 min at room temperature and 
fractionated by electrophoresis on a 5% 
polyacrylamide gels buffered with 0.5x TBE (45 
mM Tris-borate, 1 mM EDTA). The gels were 
dried onto Whatman 3MM paper and exposed to 
Hyperfilm MP (Amersham Pharmacia Biotech) 
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using amplifying screens (Cronex DuPont 
Lightning Plus). Bands corresponding to free 
DNA probes and KstR-DNA complex were 
quantified using the program Multi Gauge V 3.0 
(FUJIFILM). The apparent dissociation 
constants (Kd) for the binding of 5228FP DNA 
probe to KstR was estimated using data from 
EMSA titration experiments, where the amount 
of DNA was maintained constant and the 
amount of protein was varied. The intensity of 
the bands served to estimate the percentage of 
5228FP DNA probe shifted by the binding to 
KstR, and these data were plotted against the 
concentration of protein to calculate the apparent 
dissociation constant. Kd for the displacement of 
KstR from the 5228FP and PQ3 DNA probes 
was estimated using the intensity percentage of 
the non-shifted band in the presence of different 
concentrations of the putative inducers. 
 
Run-off transcription assays  
Multiple-round transcription by E. coli RNA 
polymerase (RNAP) was carried out under 
standard conditions (39), using buffer T (50 mM 
Tris-HCl at pH 7.5, 10 mM MgCl2 and 100 mM 
KCl) containing 1 mM dithiothreitol (DTT) and 
500 μg ml−1 BSA. The final volume of the 
reaction mixture was 20 μl, containing 1 nM 
supercoiled DNA plasmid pJCDPQ3 (or pJCD01 
for control reactions) (Table 1), 0.5 µM KstR, 40 
nM σ70-containing RNAP (USB), 1 mM ATP, 1 
mM GTP, 1 mM CTP, 0.1 mM UTP (Roche) 
and 2.5 µCi of [α-32P]UTP (3000 Ci/mmol) 
(Perkin Elmer). Firstly, a reaction mixture 
containing KstR (8 µl) and DNA plasmid (5 µl) 
were incubated at 37° C for 5 min. To test the 
effect of the inducers in the transcription 
reaction, these were dissolved in methanol and 
incubated with KstR for 10 min at room 
temperature before adding DNA. Elongation was 
started by the addition of 7 µl pre-warmed 
mixture containing cold nucleotides, [α-32P]UTP 
and RNAP in buffer T. The reactions were 
allowed to proceed for 5 min at 37 °C and were 
stopped by adding 10 µl loading buffer (20 mM 
EDTA pH8 in 96% v/v formamide containing 
bromophenol blue and xylene cyanol blue). 
After heating samples to 70 °C, they were 
subjected to electrophoresis on denaturing 7M 
urea - 4% polyacrylamide gels, buffered with 
0.5x TBE at 300 V. Drying, exposition and 
quantification were as described for EMSA 
experiments. 
 
RNA extraction 
RNA for RTq-PCR was extracted from 15 ml 
of cultured M. smegmatis mc2155 growing in 
cholesterol 1.8 mM, glycerol 18 mM or palmitic 
acid 3 mM as described previously (11). RNA 
was treated with the DNase I and Removal 
treatment kit (Ambion) according to 
manufacturer’s instructions. RNA quantity was 
measured using a NanoPhotometer®Pearl. 
Implen, GmbH (Munich, Germany). 
 
Real-time quantitative PCR (RTq-PCR) 
Reverse transcription was performed using 
the Transcriptor First Strand cDNA Synthesis 
Kit (Roche). Reactions were done in a volume of 
20 µl containing 1 µg of purified RNA, 60 µM 
of random hexamer primer, 1 mM of dNTPs and 
10 units of reverse transcritase. The template-
primer mixture was first denaturated by heating 
for 10 min at 65 °C and immediately cooling on 
ice. The remaining components were added and 
then incubated 10 min at 25 °C followed by 30 
min at 55 °C. Finally, the reverse transcriptase 
was inactivated by heating 5 min at 85 °C. Real-
time quantitative polymerase chain reactions for 
the analysis of the expression of single genes 
were performed using a LightCycler® 480 
instrument (Roche). Reactions contained 5 µl of 
a 1:5 cDNA dilution, 0.25 µM of each primer 
(Table 1) and 10 µl of LightCycler® 480 SYBR 
Green I Master (Roche) in a total volume of 20 
µl. The reactions were denatured at 95 °C for 5 
min before cycling for 50 cycles of 95 °C for 10 
s, 62 °C for 10 s and 72 °C for 10 s. Each gene 
was measured in triplicate in three independent 
experiments. The relative amount of mRNA for 
each gene was determined using the mRNA 
levels of sigA (MSMEG_2758) as internal 
control (40). 
 
 
RESULTS 
 
KstR-effector interaction analyzed by thermal 
denaturation—We assumed that the previous 
EMSA analyses to determine KstR interaction 
with its postulated inducers, i.e., cholesterol or 
cholestenone, did not render positive results due 
the low solubility of these compounds and the 
presence of detergents interfering with the 
interactions (20). This assumption prompted us 
to study the KstR-effector interactions by 
circular dichroism (CD) to monitor the 
conformational changes produced by these 
interactions and effects on the thermal stability 
of the regulator in less complex conditions (i.e., 
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in the absence of DNA) (35). In the absence of 
ligands, KstR showed a denaturation profile 
consistent with two states, folded and unfolded 
(Fig. 2A, black squares symbol), and a Tm of 
62.4 ± 0.1°C (Table 2). The addition of 0.5 mM 
of cholesterol or cholestenone did not induce any 
significant changes in the thermal denaturation 
profile (Table 2), suggesting that these 
compounds do not interact with KstR, as 
previously reported (20). 
In microarray assays, Schnappinger et al. (23) 
showed that palmitic acid induced the expression 
of several genes in the kstR regulon in M. 
tuberculosis, suggesting that perhaps this 
compound could be an effector of KstR. 
Surprisingly, when we tested the effect of 
palmitic acid on the thermal stability of KstR, 
we observed that higher concentrations of this 
compound resulted in lower KstR thermal 
stability, reaching a maximum of 41°C at 
saturating concentrations (i.e., 250 µM) (Figure 
2A; Table 2). This reduced thermal stability 
clearly indicates drastic conformational changes, 
which occur upon binding of palmitic acid to 
KstR. This effect could only be reproduced with 
long-chain fatty acids, like oleic acid (Table 2). 
The corresponding long-chain alcohols, 
palmitoyl and oleyl alcohols did not significantly 
affect the stability of KstR even at 500 µM. 
Neither did medium-chain fatty acid, its 
corresponding alcohols (octanoic acid and 
octanol) or alkanes (decane) (Table 2). These 
results indicated that only compounds with a 
long hydrophobic carbon-chain and carboxylic 
moiety were able to induce the conformational 
changes which reduced the thermal stability of 
KstR. 
To check whether the changes observed in 
the presence of palmitic acid might be due to 
detergent effects, we analyzed the influence of 
two typical detergents: cholic and deoxycholic 
acids (Fig. 2D). However, these molecules did 
not alter KstR stability and, therefore, the effect 
of palmitic acid cannot be ascribed to detergent 
effects. 
We realized that two hydrophobic acid 
substances, 3-β-hydroxy-5-cholestenoic acid 
(3OHChA) and 3-oxo-4-cholestenoic acid 
(3OChA) (Fig. 1) that are produced in the initial 
steps of the cholesterol catabolic pathway (see 
Introduction) have structural similarities with 
palmitic acid, i.e., they have a carboxylic acid 
group at C26 and an aliphatic side-chain at C17. 
When we tested both molecules by CD, they also 
induced a huge reduction in the Tm of KstR (43 
and 34°C, respectively at a concentration of 250 
µM) (Table 2). 3OHChA induced the same 
denaturation profile in KstR as palmitic acid, 
showing both states: folded and unfolded (Fig. 
2B). However, the denaturation profile induced 
by 3OChA was very different, showing two 
denaturation states at lower concentrations (i.e., 
≤ 50 µM) and a bimodal profile at higher 
concentrations (i.e., ≥ 100 µM) (Fig. 2C). The 
bimodal profile is consistent with the presence of, 
at least, three states (folded, intermediate and 
unfolded). This bimodal behavior suggested that 
the conformational changes induced by the 
interaction of the ligand with the protein could 
affect both repressor domains (i.e., DNA- and 
effector-binding domains) differently and 
consequently relax the interactions between 
them and permit observation of two separate 
transitions, corresponding to two structurally 
independent domains. The clear effect of 
3OHChA and 3OChA on the thermal stability of 
KstR suggested that they, or other related 
substances, could be inducers of the kstR regulon, 
rather than cholesterol or cholestenone, as 
postulated previously. 
Therefore, we also checked whether KstR 
thermal stability was affected by other 
intermediate compounds of the catabolic 
pathway, such as choles-5-ene-3β,26-diol 
(26OHCh), 4-androstene-3,17-dione (AD) and 
1,4-androstadiene-3,17-dione (ADD) (Fig. 1). 
Interestingly, 26OHCh is the first catabolic 
intermediate resulting from oxidation of the 
aliphatic side-chain by the P450 cytochromes 
CYP125 and CYP142, whereas AD and ADD 
are central metabolites lacking the aliphatic side-
chain. None of these compounds showed any 
significant effect on the thermal stability of the 
regulator (Table 2). These results reinforced our 
hypothesis that the aliphatic side-chain and the 
carboxylic group in the molecule are necessary 
to support the interaction of the effector with 
KstR. 
To further analyze the effect of inducers in 
the KstR structure, we determined the far-UV 
CD spectra of KstR in both the absence and 
presence of palmitic acid, 3OHChA and 3OChA 
(Fig. 3) and estimated its secondary structure 
content (Table 3). As expected, the spectrum of 
the free KstR (Fig. 3, black line) corresponds to 
a protein with a high α-helical content (63 %), in 
reasonable agreement with the α-helical content 
of the crystallographic structure of M. 
tuberculosis KstR (84%, PDB ID 3MNL). The 
addition of palmitic acid (Fig. 3, red line), 
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3OHChA (Fig. 3, green line) and 3OChA (Fig. 3, 
blue line) at saturating concentrations (250 µM), 
showed a significant decrease in α-helical 
content of the protein by 50, 39, and 44%, 
respectively (Table 3). This reduction in α-
helical content is consistent with the lower 
thermal stability of KstR observed on adding 
these compounds. 
 
KstR is homodimeric in solution—Many 
TetR-family regulators show a homodimeric 
arrangement (21). Given the major changes in 
secondary structure content of KstR induced 
upon binding of the putative effectors, we 
performed analytical ultracentrifugation and 
dynamic light scattering experiments to check 
whether, upon binding, these compounds were 
able to modify the homodimeric arrangement of 
free KstR observed in solution. The 
sedimentation velocity profiles (Fig. 4) and the 
calculated molecular mass obtained using the 
svedberg equation with the values of the 
sedimentation and the diffusion coefficients 
(data not shown) showed that most of the KstR 
protein was present as a dimer in the solution, 
independent of effectors presence or absence. 
Curiously, a small fraction of KstR was present 
as a tetramer (~ 14 %), but the physiological 
relevance of this finding is uncertain given the 
high concentration of the purified protein in the 
assay. 
 
3-β-oxo-cholestenoic acid released KstR-
DNA interaction—To determine whether the 
putative inducers of KstR promoting thermal 
instability were able to release the KstR binding 
from its target DNA, we performed EMSA 
assays using the labelled 5228FP DNA probe 
containing the P5228 promoter (20). This 
interaction is specific because an excess of 
unlabelled 5228FP DNA probe abolishes its 
retardation, whereas unspecific DNA from 
salmon sperm did not (Fig. 5A). The apparent 
dissociation constant (Kd) of KstR for the 
5228FP DNA probe (0.5 nM) deduced from 
EMSA experiments was 0.21 ± 0.07 µM (data 
not shown). 
To check whether palmitic acid, 3OHChA or 
3OChA were able to release the KstR (500 nM) 
binding from its operator region, we used the 
5228FP DNA probe (0.5 nM) in the EMSA 
assays. Fig. 5B shows that no significant 
decrease in affinity of KstR to the probe was 
observed in the presence of palmitic acid or 
3OHChA, whereas KstR was clearly released 
from DNA in the presence of 3OChA at very 
low concentrations, i.e., from 3 µM to 50 µM 
with an estimated apparent Kd of 8.5 ± 2.2 µM 
(Fig. 5D). These results suggest that only 
3OChA is able to induce the precise 
conformational change required to release the 
KstR-DNA interaction. However, when lower 
concentrations of KstR (250 nM) were used in 
the EMSA assays, interestingly, a release of the 
DNA probe was observed in the presence of 
high palmitic acid concentrations (1 mM), but 
not in the presence of 3OHChA (data not shown). 
The other compounds tested as putative 
effectors in CD experiments (Table 2) were also 
checked by gel retardation, but none of them 
released KstR from the 5228FP DNA probe (Fig. 
5C). 
 
In vitro activation of a chimeric KstR-
regulated promoter by 3OChA—In vitro 
transcription experiments were performed to 
study the functionality of KstR as a 
transcriptional repressor and to analyze the 
induction effect of 3OChA, 3OHChA and 
palmitic acid on the KstR-regulated promoters 
under conditions that could better mimic their 
physiological performances. It is noteworthy that 
previous experiments showed that the M. 
smegmatis P5228 promoter is hardly recognized in 
vitro by the E. coli RNA polymerase (RNAP) 
(data not shown) and, therefore, we designed a 
chimeric synthetic promoter PQ3 containing the -
35 and -10 boxes of the lacUV5 promoter from 
E. coli and the consensus KstR operator 
sequence from M. smegmatis. As the operator 
region of the P5228 promoter from M. smegmatis 
is located between the -10 and -35 boxes (20) we 
located the KstR operator recognition sequence 
in the same position of the chimeric PQ3 
promoter (Fig. 6A).  
To demonstrate that the PQ3 promoter is 
functional in M. smegmatis, the PQ3::lacZ 
translational fusion present in plasmid pUJ9PQ3 
was cloned into the pSEVA651 vector (Table 1), 
which replicates in M. smegmatis, resulting in 
plasmid pSEVAPQ3. As expected, the 
deregulated M. smegmatis ∆kstR (pSEVAPQ3) 
transformants turned blue in Xgal-containing 
medium, due to the expression of lacZ (Fig. 7). 
Moreover, when this recombinant strain was 
transformed with plasmid pMV6042, which 
expresses kstR, the resulting M. smegmatis ∆kstR 
(pSEVAPQ3, pMV6042) cells turned white in 
Xgal-containing medium, suggesting that KstR 
is able to repress the expression of PQ3::lacZ. 
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Similar results were obtained using the lacZ 
fusion with the native promoter P5228 (Fig. 7). 
To determine in vitro viability of the 
synthetic promoter, firstly, we checked whether 
KstR was able to recognize the PQ3 promoter by 
EMSA assays, using the labelled PQ3 DNA 
probe containing this promoter. Fig. 6B shows 
that, as expected, KstR is able to bind to the PQ3 
DNA probe in a protein concentration dependent 
manner. Furthermore, the interaction is specific 
since an excess of unlabeled PQ3 DNA probe 
abolished its retardation, while the unrelated 
DNA from salmon sperm did not. Fig. 6C shows 
that, as described above for 5228FP DNA probe, 
KstR was also released from the PQ3 DNA 
probe in the presence of a low concentration of 
3OChA. Remarkably, the effect of palmitic acid 
was greater for the PQ3 DNA probe than for the 
5228FP DNA probe. Nonetheless, higher 
concentrations of palmitic acid than 3OChA are 
required to fully release KstR (Fig. 6C). The 
apparent Kd values estimated for 3OChA and 
palmitic acid were 7.3 ± 2.4 µM and 226 ± 26 
µM, respectively, using the PQ3 DNA probe 
(0.5 nM) and KstR (500 nM) (Fig. 6E). The 
finding that 3OChA and palmitic acid released 
the KstR-PQ3 interaction more efficiently than 
the KstR-P5228, could simply be a consequence 
of a less effective interaction between KstR and 
the artificial PQ3 promoter. As described above 
for the 5228FP DNA probe, 3OHChA was 
unable to release KstR from the PQ3 DNA probe, 
suggesting that this compound is not an effector 
(Fig. 6D). 
These results indicated the possible analysis 
of the effect of KstR and the putative inducer 
molecules on transcription initiation in the 
chimeric E. coli-M. smegmatis PQ3 promoter by 
multiple-round in vitro transcription using E. 
coli RNA polymerase. For these experiments, 
the PQ3 promoter was cloned into pJCD01 
plasmid to yield pJCDPQ3 (Table 1). As 
expected, when this plasmid was used as a 
template, a 152-nt transcript was observed due to 
the PQ3 promoter activity (Fig. 8A, lanes 2-3 and 
Fig. 8B, lane 2), whereas the empty control 
plasmid pJCD01 only rendered the RNAI 
control transcript (108 nt) (Fig. 8A, lane 1 and 
Fig. 8B, lane 1) 
KstR addition to the reaction mixture 
repressed PQ3 activity (Fig. 8A, lanes 4-5 and  
Fig. 8B, lanes 3-4), demonstrating that KstR can 
repress the chimeric PQ3 promoter in vitro. 
Increasing concentrations of 3OChA (1-50 µM) 
(Fig. 8A, lanes 6-11) restored the transcription 
level of the PQ3 promoter. However, the addition 
of palmitic acid, even at high concentrations 
(250 µM) did not cause such de-repression (Fig. 
8B, lane 9 and Fig. 8C). The same negative 
result was observed in the presence of 
cholesterol, cholestenone and 3OHChA (Fig. 8B, 
lanes 5-7 and Fig 8C). These results demonstrate 
that 3OChA was the only compound able to 
activate the KstR mediated repression at the PQ3 
promoter (Fig. 8B, lane 8). 
To further discard the palmitic acid as 
effector of the KstR protein we analyzed the 
expression of several genes included in the KstR 
regulon that are upregulated in the presence of 
cholesterol by qRT-PCR experiments. As it is 
shown in figure 9, we selected some genes 
involved in the cholesterol side chain 
degradation, cyp125A3 (MSMEG_5995) and 
fadA5 (MSMEG_5996), and also genes 
implicated in the first steps of the sterol ring 
catabolism, kstD (MSMEG_5941) and kshA 
(MSMEG_5925). All the genes tested were 
induced in the presence of cholesterol but not in 
the presence of palmitic acid. These results 
confirm the in vitro transcription results in which 
the palmitic acid is not able to activate 
repression mediated by KstR. 
 
DISCUSSION 
Bacterial catabolism of cholesterol, and other 
related steroid compounds, has acquired greater 
relevance in recent years, not only because of 
their importance as environmental pollutants (41, 
42) but due to the fundamental role cholesterol 
plays in M. tuberculosis infections (22, 23, 26, 
43, 44). Expression of the genes constituting the 
cholesterol catabolic pathway is controlled by 
two proteins: KstR and KstR2 (2, 3, 19). 
Previous studies have failed to identify the 
inducer of the pathway, but it was putatively 
ascribed to cholesterol or cholestenone (2, 3, 19). 
To date, all in vitro experiments attempting to 
show that these substances could interact with 
KstR to trigger the pathway have failed (20). 
Moreover, attempts to demonstrate the 
implication of these compounds in the induction 
of KstR, by constructing M. smegmatis mutants 
blocked in the first steps of the pathway, were 
unsuccessful due to the high redundancy of the 
enzymes involved in these processes (11, 18). 
Here, the thermal denaturation analyses with 
palmitic acid constitute the first experimental 
evidence that KstR can selectively interact with 
large hydrophobic carboxylic acids. This led to 
the exploration of other carboxylic compounds 
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as putative effectors, such as 3OHChA and 
3OChA, which are the first intermediates of the 
cholesterol catabolic pathway. CD showed that 
the binding of these molecules caused a 
conformational change in KstR, drastically 
reducing its thermal stability. Such structural 
destabilization can most likely be ascribed to a 
decrease in the α-helix content, as confirmed by 
comparing the far-UV CD spectra of KstR with 
and without these compounds (Fig. 3). 
Conformational changes in the secondary 
structure caused by the binding of an effector 
have been described for other regulators, either 
repressors or activators. Interestingly, in most 
cases the effectors increased the stability of the 
protein (45-47), in contrast with the huge 
decrease in KstR stability. In this respect, most 
ligands stabilize proteins upon binding, thereby 
increasing their melting temperature; however, 
some ligands destabilize proteins by binding 
primarily to the unfolded state of the protein and 
destabilizing it (i.e., reducing protein melting 
temperature) (48). Ligands that stabilize proteins 
may be called N-binders (N-ligands, upshifters), 
and ligands that destabilize proteins may be 
called U-binders (U-ligands, downshifters) (48). 
Mathematical models that quantitatively 
describe protein destabilization by ligands 
consider ligand binding not only to the native 
state, but also to the unfolded state of the protein. 
Consequently, the KstR ligands (i.e., palmitic, 
3OHChA and 3OChA acids) can be classified as 
U-binders and appear to stabilize the unfolded 
state. 
The interaction between KstR and 3OChA 
appears to differ from that observed with 
palmitic acid or 3OHChA, as reflected by the 
atypical bimodal denaturation curve observed by 
CD. This result suggests that 3OChA induces a 
more complex effect on the KstR structure than 
the other compounds. Such a specific effect 
might be critical to release the regulator from the 
operator region of a KstR-dependent promoter. 
To test this hypothesis, we used EMSA to 
analyze the effect of these compounds on a 
system that facilitates the analysis of the triple 
interaction: effector-KstR-DNA. As expected, 
3OChA was the only compound able to release 
the binding of KstR to the DNA probe at low 
concentrations, behaving as an inducer molecule 
of KstR. However, palmitic acid required higher 
concentrations to release KstR to the DNA and 
3OHChA did not have any effect, even at very 
high concentrations, at least under the in vitro 
test conditions. 
The peculiar and specific bimodal 
denaturation curve observed by CD in the 
presence of 3OChA suggests that the structural 
changes induced in KstR by 3OChA differ 
greatly from those caused by the other acidic 
compounds, indicating conformational changes 
in both domains of the protein, i.e., DNA- and 
effector-binding domains. We propose that 
palmitic acid, oleic acid and 3OHChA bind to 
KstR due to their structural homology with 
3OChA, but they are unable to activate the 
cholesterol metabolism since they might not 
induce the specific conformational change in the 
DNA-binding domain of KstR required to 
release the KstR-DNA complex. Thus, we 
performed qRT-PCR experiments, which 
demonstrated that several genes included in the 
kstR regulon and upregulated in the presence of 
cholesterol (kstD, kshA, cyp125, fadA5) were not 
induced in presence of palmitic acid in M. 
smegmatis. Nevertheless, we cannot completely 
rule out the possibility that these compounds, 
and particularly palmitic acid and other large 
hydrophobic acids (e.g., mycolic acids) might 
play a role in the expression of the kstR regulon 
by competing with 3OChA to reach the effector 
binding-site of free KstR. 
Research has amply demonstrated the 
redundancy of enzymes involved in the first two 
steps of cholesterol catabolism (i.e., 3-β-
hydroxysteroid dehydrogenases/isomerases (3-β-
HSD) and P450 cytochromes) in mycobacteria, 
and strains presenting deletions in these genes 
still retain their ability to grow on cholesterol 
using alternative enzymes (11, 15, 17, 18, 49). 
This redundancy, together with the detection of 
constitutive basal expression levels of these 
genes in the absence of cholesterol (18, 20, 22), 
ensure rapid production of the inducer, 3OChA, 
followed by complete transcription of the kstR 
regulon. In fact, the intermediate 3OChA can be 
detected by HPLC/MS when M. smegmatis is 
growing on cholesterol or 4-cholesten-3-one (18). 
After complete oxidation of C26 to the 
corresponding carboxylic acid, the cholesterol 
side chain is shortened by a process similar to β-
oxidation of fatty acids (22, 50, 51). This process 
is initiated by a steroid CoA ligase, which 
catalyzes the CoA activation of the C26 
carboxylic acid intermediates (51, 52). Therefore, 
we cannot rule of the possibility that the 
corresponding CoA derivative of 3OChA, and 
even derivatives of 3OHChA (Fig. 1), could also 
be inducers of the KstR regulon. However, since 
these compounds are not commercially available, 
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we could not test them as putative inducers. 
Moreover, a recent study suggests that side chain 
and ring degradation of cholesterol could occur 
simultaneously in M. tuberculosis (53), therefore, 
other ring- and side chain-degraded 
intermediates of the pathway might be 
alternative inducers. 
Although other alternative inducers may exist, 
our results demonstrate, for the first time, that 
3OChA (an intermediate of the cholesterol side 
chain degradation) acts as an inducer molecule 
of the KstR repressor, allowing the expression of 
genes in the kstR regulon. We do not fully 
understand why some regulatory systems select 
an intermediate metabolite as inducer, rather 
than the initial substrate of the pathway. We 
could speculate that mycobacterial cells have 
selected 3OChA as inducer of the kstR regulon, 
instead of cholesterol, because 3OChA is more 
soluble than cholesterol. Solubility should 
facilitate its cytoplasmic diffusion, reaching the 
multiple KstR regulated promoters distributed in 
different clusters all around the chromosome. It 
is worth mentioning that the bacterial regulators 
CmeR and BreR recognize soluble bile acids as 
effectors (27, 28). 
In summary, our findings provide new 
insights into the transcriptional regulation 
mechanisms involved in the cholesterol catabolic 
pathway in mycobacteria. This is of great 
relevance given the critical role of cholesterol 
degradation in the survival of M. tuberculosis. 
The data presented here may represent the first 
step to developing new drugs aimed at disrupting 
the regulation of cholesterol catabolism, and 
help to fight the infection caused by this 
pathogen. 
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TABLE 1. Bacterial strains, plasmids and primers used in this study. 
 
Strain, plasmids or 
primers Genotype, description or sequence 
Source or 
reference 
Mycobacterium smegmatis 
  mc2155 ept-1, mc26 mutant efficient for electroporation (54) 
  mc2155 ∆kstR mc2155 strain containing a 646 bp pair deletion in the 
MSMEG_6042 gene 
(2) 
Escherichia coli 
  DH10B F-, mcrA, ∆(mrr hsdRMS-mcrBC), Φ80lacZ∆M15, 
∆lacX74, deoR, recA1, araD139, ∆(ara-leu)7697, galU, 
galK, l-, rpsL, endA1, nupG 
Invitrogen 
  BL21(DE3) F−, ompT, hsdSB(rB-mB-), gal, dcm, λDE3 (harboring gene 
1 of the RNA polymerase from the phage T7 under the 
PlacUV5 promoter) 
(31) 
Plasmids 
  pET6042 pET29a(+) cloning and expression vector (KmR, oriColE1, 
T7 promoter) containing MSMEG_6042 gene 
(20) 
  pUJ9 Promoterless lacZ vector, ApR (55) 
  pUJ9PQ3 pUJ9 vector containing the chimeric promoter PQ3 cloned 
into EcoRI and BamHI restriction sites 
This study 
  pUJ5228 pUJ9 vector containing the P5228 promoter cloned into 
EcoRI and BamHI restriction sites 
(20) 
  pJCD01 pUC19 derivative, vector for in vitro transcription, ApR (36) 
  pJCDPQ3 pJCD01 vector containing the chimeric promoter PQ3 cloned 
into EcoRI and PstI restriction sites 
This study 
  pSEVA651 Promoterless cloning vector, GmR, RFS1010 (33) 
  pSEVAP5228 pSEVA651 vector containing the P5228::lacZ translational 
fusion 
This study 
  pSEVAPQ3 pSEVA651 vector containing the PQ3::lacZ translational 
fusion 
This study 
  pMV261 Suttle expression vector for expressing genes under the 
control of pHsp60 promoter, KmR 
(34) 
  pMV6042 pMV261 containing MSMEG_6042 gene cloned into PstI 
and SalI restriction sites 
This study 
Primers 
  pUJ9PQ-F GAATTCGTACTGAGAGTGCACCATAAG This study 
  pUJ9PQ-R CTGCAGGTTTTCCCAGTCACGACGTTG This study 
  pMV6042-F CATGCTGCAGTGACCTAAGGAGGTGAATATGGCC
GGAAACTCACAG 
This study 
  pET29bhisR CATGGTCGACGTTAGCAGCCGGATCTCAGTG This study 
  pJCD01-F GCCCAGACCTGCGTTCAG This study 
  pJCD01-R GTCTTTCGACTGAGCCTTTC This study 
  MSMEG_5925 int F CGACAACGTCACCGACATGG This study 
  MSMEG_5925 int F CGTTGTGCAGGTACTGGCTG This study 
  MSMEG_5941 int F AGGTCTCGAACCGCCGTAC This study 
  MSMEG_5941 int R GACGAGGTTCTTGCCGCTG This study 
  MSMEG_5995 int F ATGTCGTCGTTCGAGCTGATC This study 
  MSMEG_5995 int R TCTGCGCGAACGCGATCATG This study 
  MSMEG_5996 int F GACATCGACATGCCCAACC This study 
  MSMEG_5996 int R TGTGGTGTCACGCAGACCC This study 
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TABLE 2. Melting temperature (Tm) of KstR in the presence of different ligands measured by 
CD in thermal denaturation experiments. 
 
 
Compound Tm (°C) ∆Tm (°C) 
No ligand 62.4 ± 0.1 ---- 
Palmitic acid 1 41.0 ± 0.1 21.4 
Oleic acid 1 48.5 ± 0.4 13.9 
3OHChA 1 43.3 ± 0.4 19.1 
3OChA 1 33.7 ± 0.5 28.7 
Cholesterol 2 63.3 ± 0.1 -0.9 
Cholest-4-en-3-ona 2 65.5 ± 0.1 -3.1 
Palmitoyl alcohol 2 61.6 ± 0.1 0.8 
Oleyl alcohol 2 61.7 ± 0.0 0.7 
Octanoic acid 2 60.5 ± 0.3 1.9 
1-Octanol 2 62.8 ± 0.1 -0.4 
Decane 2 63.7 ± 0.2 -1.3 
26OHCh 1 63.7 ± 0.1 -1.3 
AD 2 60.7 ± 0.1 1.7 
ADD 2 64.4 ± 0.1 -2.0 
1 Tested at a concentration of 250 µM  
2 Tested at a concentration of 500 µM 
26OHCh was tested at 250 µM because it was not soluble 
in 1.5% of methanol.  
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TABLE 3. Estimation of the secondary structure content of KstR in the absence and in the 
presence of different ligands. 
 
Secondary structure No ligand Palmitic acid 3OHChA 3OChA 
α-Helix (%) 63.4 50.2 39.6 44.4 
Antiparallel β-sheet (%) 3.0 5.1 9.2 8.3 
Parallel β-sheet (%) 5.1 5.2 5.8 5.9 
β-Turn (%) 12.3 14.8 14.6 14.0 
Random coil (%) 20.5 24.9 27.5 27.0 
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FIGURES LEGENDS 
 
FIGURE 1. Initial steps of aerobic cholesterol degradation in bacteria. Sterol degradation 
proceeds via steroid ring oxidation and side-chain degradation (upper route). The exact order of side-
chain degradation and ring oxidation in vivo is unknown. The depicted metabolites are: (1) cholest-5-
en-3β-ol (cholesterol), (1´) cholest-4-en-3-one, (2) cholest-5-ene-3β,26-diol o 26-hydroxycholesterol 
(26OHCh), (2´) 26-hydroxy-4-cholesten-3-one (26OHCh-3O), (3) 3-β-hydroxy-5-cholestenoic acid 
(3OHChA), (3´) 3-oxo-4-cholestenoic acid (3OChA), the corresponding CoA derivatives of 3 and 
3´(4 and 4´), (5) 4-androstene-3,17-dione (AD), (6) 1,4-androstadiene-3,17-dione (ADD). 
Abbreviations: CYP125 and CYP142, steroid 26-monoxigenases; 3-β-HSD, 3-β-hydroxysteroid 
dehydrogenase; KstD, 3-ketosteroid ∆1-dehydrogenase; FadD, steroid-CoA ligase. 
 
FIGURE 2. Interaction of KstR with palmitic acid, 3OHChA and 3OChA induce a 
conformational change that destabilizes the protein. KstR thermal denaturation profiles measured 
by circular dichroism in the presence of increasing concentration of palmitic acid (A), 3OHChA (B), 
3OChA (C) and 50 µM of sodium cholate, sodium deoxycholate and palmitic acid (D). 
 
FIGURE 3. Effect of palmitic acid, 3OHChA and 3OChA on the far-UV CD spectra of KstR. 
The addition of palmitic acid (red line), 3OHChA (green line), and 3OChA (blue line) induced a 
reduction in the amount of helical content of KstR (black line), as indicated by diminished intensity of 
the spectra in the presence of these compounds. The effect was greater with the addition of saturating 
concentrations of 3OChA or 3OHChA followed by a smaller effect for palmitic acid. 
 
FIGURE 4. Sedimentation velocity profiles of KstR. The assay was performed in absence (A) 
and presence of palmitic acid (B), 3-β-hydroxy-5-cholestenoic acid (3OHChA) (C) and 3-oxo-4-
cholestenoic acid (3OChA) (D). The distribution pattern of concentration of the protein (c(s)) is 
represented in front of the sedimentation coefficient (S). Protein concentration used was 40 µM. There 
are no differences in the oligomerization state of KstR when ligands are present, and most of the 
protein was present as a dimer in solution. 
 
FIGURE 5. Inhibition of KstR-P5228 interaction by 3OChA. (A) Analysis by EMSA of KstR 
binding to the P5228 promoter. 5228FP probe concentration was 0.5 nM. Purified KstR were used at: 
lane 1 (0 nM), lane 2 (100 nM), lane 3 (500 nM), lane 4 (1 µM). For lanes 5-10 KstR concentration 
was 500 nM. Lanes 5-7 contained unlabelled 5228FP DNA probe (40, 400 and 4000 fold 
respectively). Lanes 8-10 contained unrelated DNA from salmon sperm (0.5, 1.0 and 2.0 µg, 
respectively). (B) Analysis by EMSA of the KstR-5228FP DNA probe complex in the presence of 
3OChA, palmitic acid and 3OHChA. KstR concentration was 500 nM, except in lanes 1 and 16 (0 
nM). 3OChA (lanes 4-9), palmitic acid (lanes 10-15) and 3OHChA (lanes 19-24) were added at: 1, 3, 
6, 12, 25 and 50 µM. KstR plus 5% of methanol (lane 3 and 18) was included as control. (C) Analysis 
by EMSA of the KstR-5228FP complex in the presence of related compounds at 250 µM: 
cholestenone (lane 4), cholesterol (lane 5), 3OChA (lane 6), 3OHChA (lane 7), 1,4-androstadiene-
3,17-diona (ADD) (lane 8), palmitic acid (lane 9), palmitoyl alcohol (lane 10), oleic acid (lane 11), 
oleyl alcohol (lane 12), 1-octanol (lane 13), octanoic acid (lane 14). Controls without inducers (lane 2) 
and with 5% of methanol were included. KstR concentration was 500 nM except in lane 1 (0 nM). (D) 
Determination of the apparent Kd for KstR binding to the 5228FP probe in the presence of 3OChA. 
The apparent Kd is the 3OChA concentration at which 50% of the total DNA probe was bound to 
KstR. This value was determined from the experiment in panel B.  
 
FIGURE 6. KstR binding to the chimeric promoter PQ3 in the presence of 3OChA and 
palmitic acid. (A) Sequence of P5228, PlacUV5 and PQ3. The operator sequence for KstR at P5228 and PQ3 
promoters is boxed in dark grey. The –35 and –10 boxes, the ribosome binding sites (RBS) and the 
transcription start site (+1) are indicated. LacI operator sequence at PlacUV5 and PQ3 is boxed in light 
grey. Direction of transcription is indicated by an arrow. (B) Analysis by EMSA of KstR binding to 
the PQ3 promoter. PQ3 probe concentration was 0.5 nM. Concentrations of purified KstR used: lane 1, 
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6 (0 nM), lane 2 (100 nM), lane 3 (250 nM), lane 4 (500 nM), lane 5 (1 µM), lanes 7-13 (500 nM). 
Lanes 8-10 contain unlabelled PQ3 DNA probe (40, 400 and 4000 fold, respectively) and lanes 11-13 
contain unrelated DNA from salmon sperm (0.5, 1.0 and 2.0 µg, respectively). (C) Analysis by EMSA 
of the KstR-PQ3 DNA probe complex in the presence of 3OChA and palmitic acid. KstR 
concentration was 500 nM, except in lane 1 (0 nM). 3OChA (lanes 4-9) was added at: 1, 3, 6, 12, 25 
and 50 µM. Palmitic acid (lanes 10-15) was added at: 10, 50, 100, 250, 500 µM and 1 mM. KstR 
containing 5% of methanol (lane 3) was also included as control. (D) Analysis by EMSA of the KstR-
PQ3 DNA probe complex in the presence of 3OHChA. KstR concentration was 500 nM, except in 
lane 1 (0 nM). 3OHChA (lanes 4-9) was added at: 10, 50, 100, 250, 500 µM and 1 mM. KstR 
containing 5% methanol (lane 3) was also included as control. (E) Determination of apparent Kd for 
KstR binding to the PQ3 DNA probe in the presence of 3OChA and palmitic acid. The apparent Kd is 
the compound concentration at which 50% of the total probe was bound to KstR. This value was 
determined from the experiment in panel C. 
 
FIGURE 7. β-galactosidase assays in M. smegmatis ∆kstR strains harboring the P5228::lacZ (A) 
and PQ3::lacZ (B) translational fusions. Repression of the transcription of the lacZ gene in the 
presence of KstR (pMV6042) in strains M. smegmatis ∆kstR (pSEVAP5228) (C) and M. smegmatis 
∆kstR (pSEVAPQ3) (D). 
 
FIGURE 8. 3OChA induces transcription from KstR-repressed promoters in vitro. Multiple-
round in vitro transcription was performed in the presence of 40 nM of RNAp and 500 nM of KstR. 
+/− indicates the presence or absence of KstR and methanol in each reaction. PQ3-derived mRNA (152 
nt) and the vector derived mRNA control (RNAI, 108-109 nt) are indicated. (A) Multiple-round in 
vitro transcription in the presence of increasing concentrations of 3OChA. Reactions were carried out 
with the plasmid pJCD01 as a control (lane 1) and plasmid pJCDPQ3 containing the PQ3 promoter 
(lanes 2-11). 3OChA was added at 1, 3, 6, 12, 25 and 50 µM (lanes 6-11). (B) Multiple-round in vitro 
transcription in the presence of 250 µM of cholesterol, cholestenone, 3OHChA, 3OChA and palmitic 
acid (lanes 5-9). Reactions were performed with the plasmid pJCD01 (lane 1) and pJCDPQ3 (lanes 2-
9). The picture is a representative example of four experiments. (C) PQ3 transcription levels from 
pJCDPQ3 in the presence of KstR and inducers. The intensity of the bands observed in the in vitro 
transcription experiments (Fig. 8B) was used to calculated the transcription percentages, taking into 
account the intensity of the band in the absence of KstR (Fig. 8B, lane 2) as 100% of the transcription. 
Bars represent averages of four independent experiments and errors bars indicate ± 1 standard 
deviation. (OL: Cholesterol, ONE: cholestenone, 3OHChA: 3-β-hydroxy-5-cholestenoic acid, 3OChA: 
3-oxo-4-cholestenoic acid, PA: palmitic acid) 
 
FIGURE 9. Effect of cholesterol and palmitic acid on the expression levels of kshA 
(MSMEG_5925), kstD (MSMEG_5941), cyp125A3 (MSMEG_5995) and fadA5 (MSMEG_5996) in 
M. smegmatis. The data represent the fold change relative to expression in glycerol. Error bars 
represent standard deviation calculated from the results of three independent experiments.  
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